In BC, inhibitors of NF-κB signaling (parthenolide, pyrrolidinedithiocarbamate, and its analog diethyldithiocarbamate) inhibited MCF7 mammosphere growth, suggesting its preferential targeting of BCSC [234]. Here, NFKB1 is linked to breast cancer.